OTRIVIN 0.1% Nebulization

Xylometazoline Hydrochloride 0.1% Nasal prep
1mg/ml
Novartis Consumer Health SA
Pack size 10ml Bottle
Dispensing mode POM
Source SWITZERLAND
AgentCITY MEDICAL STORE
Retail Price 11.00 AED

Indications

OTRIVIN 0.1% Nebulization is used for: Sinusitis, Nasal congestion, Seasonal & perennial allergic rhinitis

Adult Dose

Adults: Nasal drop: 2 or 3 drops adult formula (0.1%) 2-3 times daily. Nasal spray: 2-3 sprays each nostril 3 times daily.

Child Dose

Renal Dose

Administration

Contra Indications

Contraindicated in patients with a known hypersensitivity to any ingredients of the preparation.

Precautions

The prolonged use or abuse of decongestants in general may lead to rebound congestion or drug induced rhinitis.

Pregnancy-Lactation

Pregnancy Category: C Lactation: not known if excreted in breast milk

Interactions

Increased heart rate or BP with sibutramine. Potentially Fatal: Hypertensive crisis with MAOIs.

Adverse Effects

Side effects of Xylometazoline Hydrochloride 0.1% Nasal prep : Anxiety, Dizzy, Tremor, Overuse may cause rebound congestion, Topical products may cause local side effects such as nasal burning, stinging, dryness.

Mechanism of Action

Xylometazoline is a direct-acting sympathomimetic which has a vasoconstrictor effect by reducing swelling and congestion when applied to mucous membranes.

Note

OTRIVIN 0.1% 1mg/ml Nebulization manufactured by Novartis Consumer Health SA. Its generic name is Xylometazoline Hydrochloride 0.1% Nasal prep. OTRIVIN 0.1% is availble in United Arab Emirates. Farmaco UAE drug index information on OTRIVIN 0.1% Nebulization is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Xylometazoline Hydrochloride 0.1% Nasal prep :